Nutriband Inc.

NTRB Healthcare Biotechnology

Nutriband Inc.’s revenue for fiscal 2026 (year ended January 2026) was $2.0 million, down 4.80% from fiscal 2025.

Revenue
−29.7%
EPS
+96.7%
Free cash flow
+55.5%
Total debt
−46.9%

Quarter to July 2026, against a year earlier

5.57 0.01 −0.18%
Market cap
$67.8M
P/E
0.0×
Fwd P/E
4.6×
Dividend yield
—
F-score
3/9
Altman Z
27.17
Beneish M
−3.51
Dividend safety
n/a
Older periods Oct '25 Jan '26 Apr '26 Jul '26
Piotroski F-Score

+8 more TTM periods

5 3 4 3
ROE
(368.44%) (458.50%) (539.15%) (100.79%)
ROA
(330.04%) (400.11%) (458.38%) (84.56%)
ROIC
(352.65%) (242.87%) (253.24%) (227.92%)
Return on Tangible Assets
(614.36%) (629.63%) (730.55%) (202.27%)
Average Days of Receivables
23.65 21.22 0.53 5.32
Free Cash Flow per Share
(0.47) (0.44) (0.36) (0.30)
Free Cash Flow
(5.65) (5.14) (4.36) (3.63)
Other line items

Show all line items

Columns are period end dates